NewAmsterdam Pharma Company N.V. (NAMS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for NewAmsterdam Pharma Company N.V., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -19.69x | -10.04x | -5.19x | -9.13x | -4.14x | -26.82x |
| P/B Ratio | 5.87x | 3.20x | 3.18x | 0.48x | 3.06x | 1.48x |
| P/S Ratio | 178.34x | 53.22x | 65.13x | 2.01x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 99.7% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% |
| Operating Margin | -1002.9% | -386.9% | -1298.6% | -3.5% | 0.0% | 0.0% |
| Net Margin | -905.7% | -530.3% | -1255.8% | -22.0% | 0.0% | 0.0% |
| EBITDA Margin | -1076.9% | -530.0% | -1255.2% | -21.8% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 7.88x | 8.08x | 6.95x | 13.26x | 5.96x | 7.90x |
| Quick Ratio | 7.88x | 8.08x | 6.95x | 13.26x | 5.96x | 7.90x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..